These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 27239921)

  • 21. MMP-3 as a predictor for structural remission in RA patients treated with MTX monotherapy.
    Shiozawa K; Yamane T; Murata M; Yoshihara R; Tsumiyama K; Imura S; Shiozawa S
    Arthritis Res Ther; 2016 Feb; 18():55. PubMed ID: 26922083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Matrix Metalloproteinases-3 Baseline Serum Levels in Early Rheumatoid Arthritis Patients without Initial Radiographic Changes: A Two-Year Ultrasonographic Study.
    Prodanovic SZ; Radunovic G; Babic D; Ristic B; Sefik-Bukilica M; Zlatanovic M; Simic-Pasalic K; Seric S; Vujasinovic-Stupar N; Samardzic J; Damjanov N
    Med Princ Pract; 2018; 27(4):378-386. PubMed ID: 29794470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early combination disease-modifying antirheumatic drug therapy and tight disease control improve long-term radiologic outcome in patients with early rheumatoid arthritis: the 11-year results of the Finnish Rheumatoid Arthritis Combination Therapy trial.
    Rantalaiho V; Korpela M; Laasonen L; Kautiainen H; Järvenpää S; Hannonen P; Leirisalo-Repo M; Blåfield H; Puolakka K; Karjalainen A; Möttönen T;
    Arthritis Res Ther; 2010; 12(3):R122. PubMed ID: 20576092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A genetic variant in the region of MMP-9 is associated with serum levels and progression of joint damage in rheumatoid arthritis.
    de Rooy DP; Zhernakova A; Tsonaka R; Willemze A; Kurreeman BA; Trynka G; van Toorn L; Toes RE; Huizinga TW; Houwing-Duistermaat JJ; Gregersen PK; van der Helm-van Mil AH
    Ann Rheum Dis; 2014 Jun; 73(6):1163-9. PubMed ID: 23696630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum matrix metalloproteinase 3 as a predictor of the degree of joint destruction during the six months after measurement, in patients with early rheumatoid arthritis.
    Yamanaka H; Matsuda Y; Tanaka M; Sendo W; Nakajima H; Taniguchi A; Kamatani N
    Arthritis Rheum; 2000 Apr; 43(4):852-8. PubMed ID: 10765930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum IL-1beta levels are associated with the presence of erosions in recent onset rheumatoid arthritis.
    Eklund KK; Leirisalo-Repo M; Ranta P; Mäki T; Kautiainen H; Hannonen P; Korpela M; Hakala M; Järvinen P; Möttönen T
    Clin Exp Rheumatol; 2007; 25(5):684-9. PubMed ID: 18078614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum matrix metalloproteinase 3 levels in comparison to C-reactive protein in periods with and without progression of radiological damage in patients with early rheumatoid arthritis.
    Posthumus MD; Limburg PC; Westra J; van Leeuwen MA; van Rijswijk MH
    Clin Exp Rheumatol; 2003; 21(4):465-72. PubMed ID: 12942698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progression of radiographic joint damage in rheumatoid arthritis: independence of erosions and joint space narrowing.
    Smolen JS; van der Heijde DM; Aletaha D; Xu S; Han J; Baker D; St Clair EW
    Ann Rheum Dis; 2009 Oct; 68(10):1535-40. PubMed ID: 18957487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The presence of rheumatoid nodules at early rheumatoid arthritis diagnosis is a sign of extra-articular disease and predicts radiographic progression of joint destruction over 5 years.
    Nyhäll-Wåhlin BM; Turesson C; Jacobsson LT; Nilsson JÅ; Forslind K; Albertsson K; Rönnelid J; Petersson IF
    Scand J Rheumatol; 2011 Mar; 40(2):81-7. PubMed ID: 20919947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A simplified baseline prediction model for joint damage progression in rheumatoid arthritis: a step toward personalized medicine.
    de Punder YM; van Riel PL; Fransen J
    J Rheumatol; 2015 Mar; 42(3):391-7. PubMed ID: 25593237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Matrix metalloproteinase-3 levels in relation to disease activity and radiological progression in rheumatoid arthritis.
    Tuncer T; Kaya A; Gulkesen A; Kal GA; Kaman D; Akgol G
    Adv Clin Exp Med; 2019 May; 28(5):665-670. PubMed ID: 30740946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cigarette smoking and radiographic progression in rheumatoid arthritis.
    Finckh A; Dehler S; Costenbader KH; Gabay C;
    Ann Rheum Dis; 2007 Aug; 66(8):1066-71. PubMed ID: 17237117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Baseline serum level of matrix metalloproteinase-3 as a biomarker of progressive joint damage in rheumatoid arthritis patients.
    Galil SM; El-Shafey AM; Hagrass HA; Fawzy F; Sammak AE
    Int J Rheum Dis; 2016 Apr; 19(4):377-84. PubMed ID: 25292349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum proteomic analysis identifies interleukin 16 as a biomarker for clinical response during early treatment of rheumatoid arthritis.
    Murota A; Suzuki K; Kassai Y; Miyazaki T; Morita R; Kondo Y; Takeshita M; Niki Y; Yoshimura A; Takeuchi T
    Cytokine; 2016 Feb; 78():87-93. PubMed ID: 26700586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of new bone erosion in rheumatoid arthritis patients receiving conventional synthetic disease-modifying antirheumatic drugs: Analysis of data from the DRIVE and DESIRABLE studies.
    Takeuchi T; Soen S; Ishiguro N; Yamanaka H; Tanaka S; Kobayashi M; Okubo N; Nitta T; Tanaka Y
    Mod Rheumatol; 2021 Jan; 31(1):34-41. PubMed ID: 31826682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum matrix metalloproteinase 3 in early rheumatoid arthritis is correlated with disease activity and radiological progression.
    Posthumus MD; Limburg PC; Westra J; van Leeuwen MA; van Rijswijk MH
    J Rheumatol; 2000 Dec; 27(12):2761-8. PubMed ID: 11128661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Usefulness of power Doppler ultrasound for prediction of re-therapy with rituximab in rheumatoid arthritis: a prospective study of longstanding rheumatoid arthritis patients.
    Reiche BE; Ohrndorf S; Feist E; Messerschmidt J; Burmester GR; Backhaus M
    Arthritis Care Res (Hoboken); 2014 Feb; 66(2):204-16. PubMed ID: 23925935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical synovitis in a particular joint is associated with progression of erosions and joint space narrowing in that same joint, but not in patients initially treated with infliximab.
    Klarenbeek NB; Güler-Yüksel M; van der Heijde DM; Hulsmans HM; Kerstens PJ; Molenaar TH; de Sonnaville PB; Huizinga TW; Dijkmans BA; Allaart CF
    Ann Rheum Dis; 2010 Dec; 69(12):2107-13. PubMed ID: 20610442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 'Insights in the relationship of joint space narrowing versus erosive joint damage and physical functioning of patients with RA'.
    Koevoets R; Dirven L; Klarenbeek NB; van Krugten MV; Ronday HK; van der Heijde DM; Huizinga TW; Kerstens PS; Lems WF; Allaart CF
    Ann Rheum Dis; 2013 Jun; 72(6):870-4. PubMed ID: 22753403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppression of active, but not total MMP-3, is associated with treatment response in a phase III clinical study of rheumatoid arthritis.
    Siebuhr AS; Kjelgaard-Petersen CF; Sun S; Byrjalsen I; Christiansen C; Karsdal MA; Bay-Jensen AC
    Clin Exp Rheumatol; 2018; 36(1):94-101. PubMed ID: 28850021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.